https://pipelinereview.com/itm-and-merck-kgaa-sign-research-evaluation-and-option-agreement-to-develop-folate-receptor-targeted-radionuclide-therapy/
ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy